Your browser doesn't support javascript.
loading
Hypocellular acute myeloid leukemia treated with bone marrow transplantation.
Keino, Dai; Kondoh, Kensuke; Ohyama, Ryo; Morimoto, Mizuho; Mori, Tetsuya; Ito, Masafumi; Kinoshita, Akitoshi.
Afiliação
  • Keino D; Department of Pediatrics, St Marianna University School of Medicine Hospital, Kawasaki, Japan.
  • Kondoh K; Department of Pediatrics, St Marianna University School of Medicine Hospital, Kawasaki, Japan.
  • Ohyama R; Department of Pediatrics, St Marianna University School of Medicine Hospital, Kawasaki, Japan.
  • Morimoto M; Department of Pediatrics, St Marianna University School of Medicine Hospital, Kawasaki, Japan.
  • Mori T; Department of Pediatrics, St Marianna University School of Medicine Hospital, Kawasaki, Japan.
  • Ito M; Department of Pathology, Japanese Red Cross, Nagoya Daiichi Hospital, Nagoya, Japan.
  • Kinoshita A; Department of Pediatrics, St Marianna University School of Medicine Hospital, Kawasaki, Japan.
Pediatr Int ; 59(4): 490-493, 2017 Apr.
Article em En | MEDLINE | ID: mdl-28401745
ABSTRACT
Hypocellular acute myeloid leukemia (AML) mainly occurs in elderly patients, and is extremely rare in childhood. There is still no established treatment for hypocellular AML. We report the case of an 11-year-old boy with hypocellular AML who was treated successfully with allogenic bone marrow transplantation (allo-BMT). He presented with fever, pallor and pancytopenia. Bone marrow aspiration and biopsy confirmed a diagnosis of hypocellular AML. Although low-dose cytarabine induced reduction of blasts, it did not lead to complete remission. He subsequently received myeloablative conditioning and allo-BMT. Graft-versus-host disease (GVHD) prophylaxis included short-course methotrexate and cyclosporine. Neutrophil engraftment (>5 × 108 /L) and platelet recovery (>10 × 1010 /L) were achieved on days 13 and 27, respectively. He developed acute GVHD of the skin (grade 2), which responded well to treatment with prednisolone. He has remained in complete remission for 5 years since allo-BMT. We consider allo-BMT to be feasible for children with hypocellular AML.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia / Tratamento / Transplante_de_medula_ossea Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Medula Óssea Limite: Child / Humans / Male Idioma: En Revista: Pediatr Int Assunto da revista: PEDIATRIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia / Tratamento / Transplante_de_medula_ossea Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Medula Óssea Limite: Child / Humans / Male Idioma: En Revista: Pediatr Int Assunto da revista: PEDIATRIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão